Robert J. Spiegel is Director of Athenex, Inc.. Currently has a direct ownership of 4,592 shares of ATNX, which is worth approximately $45. The most recent transaction as insider was on Apr 21, 2023, when has been sold 2,300 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $2,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.59K
0% 3M change
0% 12M change
Total Value Held $45

Robert J. Spiegel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 21 2023
BUY
Grant, award, or other acquisition
$2,990 $1.3 p/Share
2,300 Added 33.37%
4,592 Common Stock
Jan 13 2023
BUY
Grant, award, or other acquisition
$3,064 $0.19 p/Share
16,130 Added 26.03%
45,830 Common Stock
Oct 07 2022
BUY
Grant, award, or other acquisition
$2,989 $0.24 p/Share
12,453 Added 29.54%
29,700 Common Stock
Aug 03 2022
BUY
Exercise of conversion of derivative security
-
8,750 Added 33.66%
17,247 Common Stock
Jul 20 2022
BUY
Grant, award, or other acquisition
$3,020 $0.67 p/Share
4,508 Added 34.66%
8,497 Common Stock
Apr 08 2022
BUY
Grant, award, or other acquisition
$2,992 $0.75 p/Share
3,989 Added 50.0%
3,989 Common Stock

Also insider at

GERN
GERON CORP Healthcare
AYLA
Ayala Pharmaceuticals, Inc. Healthcare
CYCC
Cyclacel Pharmaceuticals, Inc. Healthcare
ADXSD
Advaxis, Inc.
RNXT
RenovoRx, Inc. Healthcare
RJS

Robert J. Spiegel

Director
Buffalo, NY

Track Institutional and Insider Activities on ATNX

Follow Athenex, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATNX shares.

Notify only if

Insider Trading

Get notified when an Athenex, Inc. insider buys or sells ATNX shares.

Notify only if

News

Receive news related to Athenex, Inc.

Track Activities on ATNX